risedronic acid has been researched along with Sarcoidosis in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T | 1 |
| Inoue, Y | 1 |
| Hayashi, S | 1 |
| Yamamoto, S | 1 |
| Sakatani, M | 1 |
1 other study available for risedronic acid and Sarcoidosis
| Article | Year |
|---|---|
Risedronate induced BOOP complicated with sarcoidosis.
Topics: Aged; Calcium Channel Blockers; Cryptogenic Organizing Pneumonia; Etidronic Acid; Female; Humans; Mu | 2005 |